Exocrine Pancreatic Insufficiency Therapeutics Market Size, Share & Industry Analysis, By Therapy (Pancreatic Enzyme Replacement Therapy (PERT), Nutritional Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Others) and Regional Forecast, 2019-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI100652

THANK YOU

FOR YOUR INTEREST IN OUR REPORT

Are you interested in exploring our consulting services?

I want to learn more about:

Competitive Intelligence Opportunity Assessment Distribution & Supply Chain Analysis Book a consultation to discuss your needs

Market Entry Strategy Go-to-market Strategy Others (Please specify)

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Prevalence of Major Disorders Associated With Exocrine Pancreatic Insufficiency
2. Pipeline Analysis
3. Recent Industry Developments Such as Mergers, Partnerships & Acquisitions
4. Regulatory Scenario
5. New Product Launches
Global Exocrine Pancreatic Insufficiency Therapeutics Market Analysis, Insights and Forecast, 2015-2026
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Therapy
  1. Pancreatic Enzyme Replacement Therapy (PERT)
    1. Creon
    2. Zenpep
    3. Others
  2. Nutritional Therapy
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Others
4. Market Analysis, Insights and Forecast – By Country
  1. North America
  2. Europe
  3. Asia Pacific
  4. Rest of the World
North America Exocrine Pancreatic Insufficiency Therapeutics Market Analysis, Insights and Forecast, 2015-2026
1. Key Findings / Summary
2. Market Analysis – By Therapy
  1. Pancreatic Enzyme Replacement Therapy (PERT)
    1. Creon
    2. Zenpep
    3. Others
  2. Nutritional Therapy
3. Market Analysis – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Others
4. Market Analysis – By Country
  1. U.S.
  2. Canada
Europe Exocrine Pancreatic Insufficiency Therapeutics Market Analysis, Insights and Forecast, 2015-2026
1. Key Findings / Summary
2. Market Analysis – By Therapy
  1. Pancreatic Enzyme Replacement Therapy (PERT)
    1. Creon
    2. Zenpep
    3. Others
  2. Nutritional Therapy
3. Market Analysis – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Others
4. Market Analysis – By Country
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Rest of Europe
Asia Pacific Exocrine Pancreatic Insufficiency Therapeutics Market Analysis, Insights and Forecast, 2015-2026
1. Key Findings / Summary
2. Market Analysis – By Therapy
  1. Pancreatic Enzyme Replacement Therapy (PERT)
    1. Creon
    2. Zenpep
    3. Others
  2. Nutritional Therapy
3. Market Analysis – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Others
4. Market Analysis – By Country
  1. Japan
  2. China
  3. India
  4. Australia
  5. Rest of Asia Pacific
Rest of the World Exocrine Pancreatic Insufficiency Therapeutics Market Analysis, Insights and Forecast, 2015-2026
1. Key Findings / Summary
2. Market Analysis – By Therapy
  1. Pancreatic Enzyme Replacement Therapy (PERT)
    1. Creon
    2. Zenpep
    3. Others
  2. Nutritional Therapy
3. Market Analysis – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Others
4. Market Analysis – By Country
Competitive Analysis
1. Key Industry Developments
2. Global Market Share Analysis (2018)
3. Competition Dashboard
4. Comparative Analysis – Major Players
5. Company Profiles
  1. AbbVie Inc.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  2. Janssen Pharmaceuticals, Inc.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  3. Allergan
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  4. AzurRx
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  5. CHIESI Farmaceutici S.p.A.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  6. Other Prominent Players
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)

Read Less

List of Figures

Figure 1: Global Exocrine Pancreatic Insufficiency Therapeutics Market Revenue Breakdown (US$ Mn, %) by Region, 2018 & 2026

Figure 2: Global Exocrine Pancreatic Insufficiency Therapeutics Market Value Share (%), by Product, 2018 & 2026

Figure 3: Global Exocrine Pancreatic Insufficiency Therapeutics Market Forecast (US$ Mn), by Pancreatic Enzyme Replacement Therapy (PERT), 2015-2026

Figure 4: Global Exocrine Pancreatic Insufficiency Therapeutics Market Forecast (US$ Mn), by Nutritional Therapy, 2015-2026

Figure 5: Global Exocrine Pancreatic Insufficiency Therapeutics Market Value Share (%), by Distribution Channel, 2018 & 2026

Figure 6: Global Exocrine Pancreatic Insufficiency Therapeutics Market Forecast (US$ Mn), by Hospital Pharmacies, 2015-2026

Figure 7: Global Exocrine Pancreatic Insufficiency Therapeutics Market Forecast (US$ Mn), by Retail Pharmacies & Drug Stores, 2015-2026

Figure 8: Global Exocrine Pancreatic Insufficiency Therapeutics Market Forecast (US$ Mn), by Others, 2015-2026

Figure 9: Global Exocrine Pancreatic Insufficiency Therapeutics Market Value (US$ Mn), by Region, 2018 & 2026

Figure 10: North America Exocrine Pancreatic Insufficiency Therapeutics Market Value (US$ Mn), by Product, 2018 & 2026

Figure 11: North America Exocrine Pancreatic Insufficiency Therapeutics Market Value Share (%), by Product, 2018

Figure 12: North America Exocrine Pancreatic Insufficiency Therapeutics Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 13: North America Exocrine Pancreatic Insufficiency Therapeutics Market Value Share (%), by Distribution Channel, 2018

Figure 14: North America Exocrine Pancreatic Insufficiency Therapeutics Market Value (US$ Mn), By Country, 2018 & 2026

Figure 15: North America Exocrine Pancreatic Insufficiency Therapeutics Market Value Share (%), By Country, 2018

Figure 16: Europe Exocrine Pancreatic Insufficiency Therapeutics Market Value (US$ Mn), by Product, 2018 & 2026

Figure 17: Europe Exocrine Pancreatic Insufficiency Therapeutics Market Value Share (%), by Product, 2018

Figure 18: Europe Exocrine Pancreatic Insufficiency Therapeutics Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 19: Europe Exocrine Pancreatic Insufficiency Therapeutics Market Value Share (%), by Distribution Channel, 2018

Figure 20: Europe Exocrine Pancreatic Insufficiency Therapeutics Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 21: Europe Exocrine Pancreatic Insufficiency Therapeutics Market Value Share (%), By Country/ Sub-region, 2018

Figure 22: Asia Pacific Exocrine Pancreatic Insufficiency Therapeutics Market Value (US$ Mn), by Product, 2018 & 2026

Figure 23: Asia Pacific Exocrine Pancreatic Insufficiency Therapeutics Market Value Share (%), by Product, 2018

Figure 24: Asia Pacific Exocrine Pancreatic Insufficiency Therapeutics Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 25: Asia Pacific Exocrine Pancreatic Insufficiency Therapeutics Market Value Share (%), by Distribution Channel, 2018

Figure 26: Asia Pacific Exocrine Pancreatic Insufficiency Therapeutics Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 27: Asia Pacific Exocrine Pancreatic Insufficiency Therapeutics Market Value Share (%), By Country/ Sub-region, 2018

Figure 28: Rest of the World Exocrine Pancreatic Insufficiency Therapeutics Market Value (US$ Mn), by Product, 2018 & 2026

Figure 29: Rest of the World Exocrine Pancreatic Insufficiency Therapeutics Market Value Share (%), by Product, 2018

Figure 30: Rest of the World Exocrine Pancreatic Insufficiency Therapeutics Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 31: Rest of the World Exocrine Pancreatic Insufficiency Therapeutics Market Value Share (%), by Distribution Channel, 2018

Figure 32: Global Exocrine Pancreatic Insufficiency Therapeutics Market Share (%), By Company, 2018

List of Tables

Table 1: Global Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Product, 2015–2026

Table 2: Global Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Pancreatic Enzyme Replacement Therapy (PERT), 2015–2026

Table 3: Global Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 4: Global Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Region, 2015-2026

Table 5: North America Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Product, 2015-2026

Table 6: North America Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Pancreatic Enzyme Replacement Therapy (PERT), 2015–2026

Table 7: North America Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 8: North America Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, By Country, 2015-2026

Table 9: Europe Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Product, 2015-2026

Table 10: Europe Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Pancreatic Enzyme Replacement Therapy (PERT), 2015–2026

Table 11: Europe Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 12: Europe Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 13: Asia Pacific Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Product, 2015-2026

Table 14: Asia Pacific Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Pancreatic Enzyme Replacement Therapy (PERT), 2015–2026

Table 15: Asia Pacific Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 16: Asia Pacific Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 17: Rest of the World Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Product, 2015-2026

Table 18: Rest of the World Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Pancreatic Enzyme Replacement Therapy (PERT), 2015–2026

Table 19: Rest of the World Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 20: Rest of the World Exocrine Pancreatic Insufficiency Therapeutics Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026